This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

A Healthy Dose

By Drug Innovation and Access Initiative

An e-newsletter about our work in drug development and introduction.

Produced from 2013 to 2018, A Healthy Dose provided updates on our work to ensure that safe, effective, and affordable medicines are available and accessible to all those who need them. Each issue contained news about our research, product development milestones, clinical trial updates, awards and partnerships, and drug development resources.

This newsletter is no longer being published, but you can click on the links below to access the e-newsletter archive.

May 2018

  • Cryptosporidium researchers convene at PATH
  • Healthy guts, healthy children - tackling environmental enteric dysfunction (EED)
  • Safety and feasibility of enterade®
  • Take the Plunge with DefeatDD
  • What is EED?

March 2018

  • NutMox - one of the winners of J&J GenH Challenge
  • Dr. Mark Manary on stunting, the role of environmental enteric dysfunction, and potential solutions
  • DRC steps up commitment to eliminate HAT by 2020
  • Toilet Talks brings attention to diarrhea

November 2017

  • Tweet to Defeat: 24-hour sprint of research and innovation
  • Resource: Oxygen primer
  • DefeatDD to launch state-of-the-field report on diarrheal disease
  • Every Woman Every Child Innovation Marketplace
  • SOCAP17 in San Francisco
  • PATH at ASTMH Annual Meeting
  • 2018 Cryptosporidium Symposium

July 2017

  • New indication for oxygen on Essential Medicines List
  • New videos from DefeatDD
  • Making birth safer for mothers
  • Advancing Cryptosporidium research
  • Bay Area Global Health Innovation Challenge
  • Partnering against parasitic worms
  • Creative solutions to stop diarrhea

April 2017

  • Meet the amazing cast behind a life-changing drug
  • Elevating oxygen therapy
  • Updated and improved DefeatDD.org
  • New R&D Resource Library
  • Neglected Tropical Disease Summit 2017
  • On the ground at SXSW
  • Launch of Bay Area Leadership Council
  • Global Health Regulatory Team Convening

January 2017

  • New partnership to expand PATH’s work in soil-transmitted helminths
  • Explore new content on our subsite
  • Oxygen is a matter of life and breath
  • DefeatDD poo haiku campaign
  • Focused pharmacovigilance for kala-azar in Bangladesh and Nepal
  • Post-kala-azar dermal leishmaniasis/visceral leishmaniasis relapse study in Bangladesh
  • Presentations on diarrhea and pneumonia
  • Diarrhea Innovations Group at ASTMH Annual Meeting

Past issues of A Healthy Dose

Click on the links below to access our past issues (2013 - 2016):

October 2016

  • PATH receives prestigious Tech Award
  • Breaking the cycle of soil-transmitted helminth infections
  • DefeatDD: Superheroes vs. Villains video
  • Connecting with innovators at JLABS
  • Diarrhea Innovations Group at ASTMHOctober 2016
  • PATH receives prestigious Tech Award
  • Breaking the cycle of soil-transmitted helminth infections
  • DefeatDD: Superheroes vs. Villains video
  • Connecting with innovators at JLABS
  • Diarrhea Innovations Group at ASTMH

June 2016

  • A novel route to malaria treatments: semisynthetic artemisinin
  • Pharmacovigilance for kala-azar in Nepal
  • New factsheet: Oxygen therapy for newborn and child health
  • New DefeatDD video: The Financial, Physical, and Emotional Toll of Chronic Diarrhea
  • Diarrhea Innovations Group annual meeting
  • Bay Area global health happenings
  • A vicious cycle: diarrhea and malnutrition

March 2016

  • PATH hosts symposium on Cryptosporidium
  • Grant from GHIT Fund for intestinal worms drug research
  • ACCORD to save lives
  • Coast to coast science
  • Why is malnutrition so hard to treat?

December 2015

  • New Diarrhea Innovations Group launches
  • World Toilet Day 2015 and #TravelingPoo
  • At the ASTMH annual meeting
  • Brainstorming with Bay Area innovators
  • Engaging on nutrition in Seattle
  • PATH in San Francisco

September 2015

  • 23 countries receive antimalarials made with semisynthetic artemisinin
  • Clinical update
  • Crypto, the new old threat
  • PATH’s Bay Area office moves to San Francisco
  • On the move
  • Innovation Countdown 2030 report

June 2015

  • World Malaria Day 2015
  • Enrollment underway for HIV PrEP phase 2 trial
  • Millions of malaria drugs made with ssART shipped
  • #DefeatMalaria campaign
  • #Blue4Water on World Water Day
  • When I think of drug development…

March 2015

  • New safety trial for injectable PrEP to prevent HIV
  • Novel drug safety model for visceral leishmaniasis patients
  • PKDL Consortium advocates unified approach
  • CROI 2015
  • Investigational new drug—make it or break it

December 2014

August 2014

May 2014

February 2014

November 2013

July 2013

April 2013